Matrix Metalloproteinase 13
"Matrix Metalloproteinase 13" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A secreted matrix metalloproteinase that plays a physiological role in the degradation of extracellular matrix found in skeletal tissues. It is synthesized as an inactive precursor that is activated by the proteolytic cleavage of its N-terminal propeptide.
| Descriptor ID |
D053509
|
| MeSH Number(s) |
D08.811.277.656.300.480.205.363 D08.811.277.656.300.480.525.700.550 D08.811.277.656.675.374.205.363 D08.811.277.656.675.374.525.700.550 D12.644.276.848.550 D12.776.467.836.550
|
| Concept/Terms |
Matrix Metalloproteinase 13- Matrix Metalloproteinase 13
- Metalloproteinase 13, Matrix
- Matrix Metalloproteinase-13
- Metalloproteinase-13, Matrix
- MMP13 Metalloproteinase
- Metalloproteinase, MMP13
- MMP-13 Metalloproteinase
- MMP 13 Metalloproteinase
- Metalloproteinase, MMP-13
- Collagenase-3
- Collagenase 3
|
Below are MeSH descriptors whose meaning is more general than "Matrix Metalloproteinase 13".
Below are MeSH descriptors whose meaning is more specific than "Matrix Metalloproteinase 13".
This graph shows the total number of publications written about "Matrix Metalloproteinase 13" by people in this website by year, and whether "Matrix Metalloproteinase 13" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2004 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2009 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Matrix Metalloproteinase 13" by people in Profiles.
-
Osteoprogenitor-GMP crosstalk underpins solid tumor-induced systemic immunosuppression and persists after tumor removal. Cell Stem Cell. 2023 05 04; 30(5):648-664.e8.
-
Global gene profiling of aging lungs in Atp8b1 mutant mice. Aging (Albany NY). 2016 09 29; 8(9):2232-2252.
-
Secreted and O-GlcNAcylated MIF binds to the human EGF receptor and inhibits its activation. Nat Cell Biol. 2015 Oct; 17(10):1348-55.
-
Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells. Mol Vis. 2014; 20:1243-52.
-
Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogens. J Immunol. 2013 Aug 01; 191(3):1404-12.
-
MMP13, Birc2 (cIAP1), and Birc3 (cIAP2), amplified on chromosome 9, collaborate with p53 deficiency in mouse osteosarcoma progression. Cancer Res. 2009 Mar 15; 69(6):2559-67.
-
Ets1 induces dysplastic changes when expressed in terminally-differentiating squamous epidermal cells. PLoS One. 2009; 4(1):e4179.
-
Metalloproteinase expression in venous aneurysms. J Vasc Surg. 2008 Nov; 48(5):1278-85.
-
Steroid receptor coactivator-3/AIB1 promotes cell migration and invasiveness through focal adhesion turnover and matrix metalloproteinase expression. Cancer Res. 2008 Jul 01; 68(13):5460-8.
-
Amniotic fluid concentrations of collagenase-1 and collagenase-3 are increased in polyhydramnios. J Perinat Med. 2004; 32(2):122-5.